Cleared Traditional

K122214 - TG-970P SENSOR KIT W/ NEW AIRWAY ADAPTE...

K122214 is an FDA 510(k) clearance for TG-970P SENSOR KIT W/ NEW AIRWAY ADAPTE..., manufactured by Nihon Kohden Corp.. The device is a Class 2 Anesthesiology device with product code CCK cleared through the Traditional 510(k) pathway after a 300-day FDA review.

K122214 · Nihon Kohden Corp. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2013
Decision
300d
Days
Class 2
Risk

K122214 is an FDA 510(k) clearance for the TG-970P SENSOR KIT W/ NEW AIRWAY ADAPTER (YG-213T). Classified as Analyzer, Gas, Carbon-dioxide, Gaseous-phase (product code CCK), Class II - Special Controls.

Submitted by Nihon Kohden Corp. (Foothill, US). The FDA issued a Cleared decision on May 21, 2013 after a review of 300 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1400 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Nihon Kohden Corp. devices

FDA 510(k) Submission Details - K122214

510(k) Number K122214 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 25, 2012
Decision Date May 21, 2013
Days to Decision 300 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
160d slower than avg
Panel avg: 140d · This submission: 300d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CCK Device Classification - Class 2, Special Controls

Product Code CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1400
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase

All 180
Devices cleared under the same product code (CCK) and FDA review panel - the closest regulatory comparables to K122214.
SOFTECH Plus ETCO2 Cannula
K143469 · Teleflexmedical, Inc. · Feb 2015
CAPNOSTREAM20P WITH HIFI C02 MONITORING
K123690 · Oridion Medical 1987 , Ltd. · Aug 2014
SOFTECH PLUS ETC02 CANNULA
K132946 · Teleflexmedical, Inc. · Jun 2014
MICROSTREAM FILTERLINE ICU
K121927 · Oridion Medical 1987 , Ltd. · Nov 2012
CAPNOSTREAM20P WITH AI/ODI
K112368 · Oridion Medical 1987 , Ltd. · Jul 2012
END TIDAL CO2 NASAL CANNULA
K120518 · Care Fusion · May 2012